Clinical Trial Update: A Study to Determine the Pharmacokinetics, Pharmacodynamics, and Tolerabiltiy of Betrixaban in Patients With Mild, Moderate, and Severe Renal Impairment [Phase 1]

View source ↗

Summary

Phase 1 study investigating pharmacokinetics, pharmacodynamics, and tolerability of betrixaban in patients with varying levels of renal impairment; completed wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Impairment

Drugs mentioned

• betrixaban (betrixaban)

Snippet

Sponsor: Portola Pharmaceuticals | Conditions: Renal Impairment | Phase 1 | Status: COMPLETED | Results posted: 2023-08-22